Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
Metabolite profiling is being increasing employed in the study of prostate cancer as a means of identifying predictive, diagnostic, and prognostic biomarkers. This review provides a summary and critique of the current literature. Thirty-three human case-control studies of prostate cancer exploring d...
Main Authors: | Kelly, R. S., Giovannucci, E., Mucci, L. A., Vander Heiden, Matthew G. |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Published: |
American Association for Cancer Research (AACR)
2018
|
Online Access: | http://hdl.handle.net/1721.1/116917 https://orcid.org/0000-0002-6702-4192 |
Similar Items
-
Prostate cancer: pathophysiology, diagnosis, and prognosis
by: Falah Abass Mohamed Salih, et al.
Published: (2016) -
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
by: Feng, Xiaoshuang, et al.
Published: (2021) -
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
by: Feng, Xiaoshuang, et al.
Published: (2022) -
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
by: Dickerman, Barbra A., et al.
Published: (2020) -
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
by: Botchorishvili, G, et al.
Published: (2009)